These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25891195)

  • 1. Designing carbonic anhydrase inhibitors for the treatment of breast cancer.
    Supuran CT; Winum JY
    Expert Opin Drug Discov; 2015 Jun; 10(6):591-7. PubMed ID: 25891195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
    Supuran CT
    Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
    Carradori S
    Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
    Monti SM; Supuran CT; De Simone G
    Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibitors. Design of fluorescent sulfonamides as probes of tumor-associated carbonic anhydrase IX that inhibit isozyme IX-mediated acidification of hypoxic tumors.
    Cecchi A; Hulikova A; Pastorek J; Pastoreková S; Scozzafava A; Winum JY; Montero JL; Supuran CT
    J Med Chem; 2005 Jul; 48(15):4834-41. PubMed ID: 16033263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
    De Simone G; Supuran CT
    Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.
    Perut F; Carta F; Bonuccelli G; Grisendi G; Di Pompo G; Avnet S; Sbrana FV; Hosogi S; Dominici M; Kusuzaki K; Supuran CT; Baldini N
    Expert Opin Ther Targets; 2015; 19(12):1593-605. PubMed ID: 26357839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors.
    Touisni N; Maresca A; McDonald PC; Lou Y; Scozzafava A; Dedhar S; Winum JY; Supuran CT
    J Med Chem; 2011 Dec; 54(24):8271-7. PubMed ID: 22077347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    Mboge MY; Chen Z; Wolff A; Mathias JV; Tu C; Brown KD; Bozdag M; Carta F; Supuran CT; McKenna R; Frost SC
    PLoS One; 2018; 13(11):e0207417. PubMed ID: 30452451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug design studies of the novel antitumor targets carbonic anhydrase IX and XII.
    Guler OO; De Simone G; Supuran CT
    Curr Med Chem; 2010; 17(15):1516-26. PubMed ID: 20166929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors.
    Winum JY; Cecchi A; Montero JL; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3302-6. PubMed ID: 15908201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
    Thiry A; Dogné JM; Masereel B; Supuran CT
    Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters.
    Vullo D; Steffansen B; Brodin B; Supuran CT; Scozzafava A; Nielsen CU
    Bioorg Med Chem; 2006 Apr; 14(7):2418-27. PubMed ID: 16321542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic secondary sulfonamides: unusually good inhibitors of cancer-related carbonic anhydrase enzymes.
    Moeker J; Peat TS; Bornaghi LF; Vullo D; Supuran CT; Poulsen SA
    J Med Chem; 2014 Apr; 57(8):3522-31. PubMed ID: 24689792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbonic anhydrase inhibitors: a review on the progress of patent literature (2011-2016).
    Lomelino C; McKenna R
    Expert Opin Ther Pat; 2016 Aug; 26(8):947-56. PubMed ID: 27387065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.